Prudential Financial’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $240K | Buy |
25,433
+2,090
| +9% | +$18.7K | ﹤0.01% | 2172 |
|
|
2026
Q1 | $190K | Buy |
+23,343
| New | +$212K | ﹤0.01% | 2150 |
|
|
2025
Q4 | – | Sell |
-19,366
| Closed | -$168K | – | 2365 |
|
|
2025
Q3 | $168K | Sell |
19,366
-17,700
| -48% | -$138K | ﹤0.01% | 2230 |
|
|
2025
Q2 | $234K | Buy |
37,066
+25,563
| +222% | +$169K | ﹤0.01% | 2167 |
|
|
2025
Q1 | $73.7K | Buy |
11,503
+470
| +4% | +$3.88K | ﹤0.01% | 2162 |
|
|
2024
Q4 | $88.7K | Buy |
11,033
+570
| +5% | +$5.5K | ﹤0.01% | 2160 |
|
|
2024
Q3 | $132K | Sell |
10,463
-65
| -0.6% | -$839 | ﹤0.01% | 2558 |
|
|
2024
Q2 | $133K | Buy |
+10,528
| New | +$106K | ﹤0.01% | 2526 |
|
|
2023
Q3 | – | Sell |
-6,188
| Closed | -$354K | – | 2672 |
|
|
2023
Q2 | $354K | Buy |
+6,188
| New | +$48.7K | ﹤0.01% | 2244 |
|
|
2022
Q1 | – | Sell |
-2,196
| Closed | -$394K | – | 2666 |
|
|
2021
Q4 | $394K | Sell |
2,196
-12,542
| -85% | -$2.15M | ﹤0.01% | 2298 |
|
|
2021
Q3 | $3.13M | Buy |
14,738
+1,244
| +9% | +$274K | ﹤0.01% | 1225 |
|
|
2021
Q2 | $2.87M | Sell |
13,494
-14,803
| -52% | -$2.71M | ﹤0.01% | 1311 |
|
|
2021
Q1 | $5.13M | Buy |
28,297
+1,649
| +6% | +$329K | 0.01% | 1014 |
|
|
2020
Q4 | $2.97M | Buy |
26,648
+5,281
| +25% | +$561K | 0.01% | 1238 |
|
|
2020
Q3 | $2.31M | Buy |
21,367
+16,539
| +343% | +$2.01M | ﹤0.01% | 1267 |
|
|
2020
Q2 | $402K | Buy |
+4,828
| New | +$185K | ﹤0.01% | 1997 |
|
|
2019
Q2 | – | Sell |
-1,759
| Closed | -$19K | – | 2481 |
|
|
2019
Q1 | $19K | Buy |
1,759
+18
| +1% | +$568 | ﹤0.01% | 2424 |
|
|
2018
Q4 | $64K | Sell |
1,741
-9
| -0.5% | -$349 | ﹤0.01% | 2327 |
|
|
2018
Q3 | $66K | Sell |
1,750
-113
| -6% | -$3.18K | ﹤0.01% | 2390 |
|
|
2018
Q2 | $50K | Buy |
1,863
+308
| +20% | +$10.4K | ﹤0.01% | 2406 |
|
|
2018
Q1 | $65K | Buy |
1,555
+31
| +2% | +$1.25K | ﹤0.01% | 2313 |
|
|
2017
Q4 | $38K | Buy |
1,524
+25
| +2% | +$610 | ﹤0.01% | 2316 |
|
|
2017
Q3 | $34K | Buy |
1,499
+18
| +1% | +$403 | ﹤0.01% | 2319 |
|
|
2017
Q2 | $34K | Hold |
1,481
| – | – | ﹤0.01% | 2325 |
|
|
2017
Q1 | $38K | Hold |
1,481
| – | – | ﹤0.01% | 2314 |
|
|
2016
Q4 | $37K | Hold |
1,481
| – | – | ﹤0.01% | 2318 |
|
|
2016
Q3 | $62K | Buy |
1,481
+88
| +6% | +$11.4K | ﹤0.01% | 2295 |
|
|
2016
Q2 | $202K | Buy |
1,393
+75
| +6% | +$8.6K | ﹤0.01% | 2200 |
|
|
2016
Q1 | $136K | Sell |
1,318
-1,285
| -49% | -$138K | ﹤0.01% | 2228 |
|
|
2015
Q4 | $437K | Sell |
2,603
-11,415
| -81% | -$1.76M | ﹤0.01% | 2000 |
|
|
2015
Q3 | $1.98M | Buy |
14,018
+10,260
| +273% | +$2.3M | ﹤0.01% | 1457 |
|
|
2015
Q2 | $837K | Sell |
3,758
-19,660
| -84% | -$3.46M | ﹤0.01% | 1865 |
|
|
2015
Q1 | $3.87M | Sell |
23,418
-17,070
| -42% | -$2.77M | 0.01% | 1262 |
|
|
2014
Q4 | $4.8M | Buy |
40,488
+39,380
| +3,554% | +$4.12M | 0.01% | 1029 |
|
|
2014
Q3 | $92K | Sell |
1,108
-918
| -45% | -$83K | ﹤0.01% | 2172 |
|
|
2014
Q2 | $187K | Buy |
2,026
+1,053
| +108% | +$92.5K | ﹤0.01% | 2294 |
|
|
2014
Q1 | $88K | Sell |
973
-15
| -2% | -$1.68K | ﹤0.01% | 2217 |
|
|
2013
Q4 | $101K | Buy |
988
+105
| +12% | +$7.42K | ﹤0.01% | 2233 |
|
|
2013
Q3 | $56K | Buy |
883
+30
| +4% | +$1.69K | ﹤0.01% | 2245 |
|
|
2013
Q2 | $35K | Buy |
+853
| New | +$37K | ﹤0.01% | 2263 |
|
Other funds holding NVAX
SCM
S
Prudential Financial's NVAX Position: Q2 2026 in Review
Prudential Financial increased its Novavax (NVAX) stake by 9% in Q2 2026, buying an estimated $18.7K and bringing the position to 25,433 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #2172.
Prudential Financial first reported a position in NVAX in Q2 2013 and has held it in 40 quarters since. The position peaked at $5.13M in Q1 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- Prudential Financial held 25,433 shares of Novavax worth $240K as of Q2 2026.
- Prudential Financial bought 2,090 Novavax shares in Q2 2026, an estimated $18.7K.
- Novavax made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2172 holding.
- Prudential Financial first reported a position in Novavax in Q2 2013 and has held it in 40 quarters since.
- Prudential Financial's Novavax position peaked at $5.13M in Q1 2021.
- 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.